Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 13/20 | 0.70 |
| ▸ | MAPT | P10636 | 12/20 | 0.70 |
| ▸ | MEN1 | O00255 | 11/20 | 0.70 |
| ▸ | LMNA | P02545 | 9/20 | 0.70 |
| ▸ | HTT | P42858 | 8/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.70 |
| ▸ | GAA | P10253 | 3/20 | 0.56 |
| ▸ | RECQL | P46063 | 2/20 | 0.56 |
| ▸ | TEX264 | Q9Y6I9 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.52 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13942699 | 0.79 | KMT2A (0.77) | KMT2AMAPTMEN1LMNAHTT | |
| SCHEMBL13576487 | 0.78 | LMNA (0.81) | KMT2AMAPTMEN1LMNAHTT | |
| SCHEMBL1659816 | 0.77 | MAPT (0.62) | KMT2AMAPTMEN1LMNAHTT | |
| SCHEMBL1659812 | 0.77 | MAPT (0.62) | KMT2AMAPTMEN1LMNAHTT | |
| SCHEMBL13944051 | 0.77 | LMNA (0.70) | KMT2AMAPTMEN1LMNAHTT | |
| SCHEMBL22737807 | 0.76 | MAPT (0.68) | KMT2AMAPTMEN1LMNAHTT | |
| SCHEMBL1660591 | 0.75 | LMNA (0.68) | KMT2AMAPTMEN1LMNAHTT | |
| SCHEMBL1660585 | 0.75 | LMNA (0.68) | KMT2AMAPTMEN1LMNAHTT | |
| SCHEMBL3813156 | 0.75 | MAPT (0.66) | KMT2AMAPTMEN1LMNAHTT | |
| SCHEMBL8909400 | 0.74 | MAPT (0.57) | KMT2AMAPTMEN1LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10668076-B1 | Compositions and methods of targeting mutant K-Ras | NANTBIO, INC. (US) | 2020-06-02 | — | — | US | disclosed |
| US-9687491-B1 | Compositions and methods of targeting mutant K-Ras | NANTBIOSCIENCE, INC. (US) | 2017-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10668076-B1 | Compositions and methods of targeting mutant K-Ras | KRAS, NRAS, HRAS | KMT2A 2629/4885MAPT 3827/4885MEN1 973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.